#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-Hodgkin's lymphoma refractory Liposarcoma Small cell lung cancer extensive stage Thrombocytosis Ischaemic stroke Endometrial adenocarcinoma Haemophilia Neuroendocrine carcinoma Mitochondrial myopathy Chemical burn Gastrooesophageal cancer Hodgkin's disease refractory Non-small cell lung cancer recurrent Germ cell cancer Acute myeloid leukaemia recurrent More trials…

    Learn about Rare Diseases

    Proteus syndrome – Basic Information Myxofibrosarcoma – Life with Disease Angiosarcoma – Trials in Disease Mast cell activation syndrome Inclusion body myositis – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Waldenstrom’s macroglobulinaemia recurrent – Diagnostics Burkitt’s lymphoma Brain stem glioma – Basic Information Wiskott-Aldrich syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lithium Carbonate Cldn6 Car-T Blu-451 Potassium Oxybate LY3372993 Toripalimab Petrelintide Gfh925 IBANDRONIC ACID YL201 Seralutinib Dexmedetomidine Hydrochloride Selinexor A/H1N1 INFLUENZA VACCINE Sargramostim GOCATAMIG Cefoxitin Procarbazine Hydrochloride Camlipixant Sodium Citrate More therapies…

    Learn about Your Condition

    Hyponatraemia Ovarian cancer metastatic Cardiac failure Meningorrhagia Tumour of ampulla of Vater Eyelid ptosis Colorectal cancer stage IV Diverticulitis Testicular germ cell cancer Crigler-Najjar syndrome Thromboembolectomy Pancreatic carcinoma Adenocarcinoma gastric Vascular dementia Metastases to rectum More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study of abrocitinib oral suspension for children aged 2 years and older with moderate to severe atopic dermatitis to evaluate long-term safety and effectiveness

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Abrocitinib
    Germany Hungary Poland Spain

  • Comparing effectiveness of topical permethrin, oral ivermectin, and their combination for treating patients with confirmed scabies infection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acarodermatitis
    Investigated Drugs:
    • Ivermectin
    Italy

  • Long-term safety and effectiveness study of APG777 injection in patients with moderate-to-severe atopic dermatitis who previously received APG777 treatment

    Recruiting

    2 1
    Investigated Drugs:
    • Apg777
    Czechia France Germany Hungary Poland Spain

  • Study of Ritlecitinib Combined with Narrow Band UVB Light Therapy Compared to Ritlecitinib Alone in Adults with Vitiligo

    Recruiting

    2 1 1 1
    France

  • Study of Delgocitinib Cream for Adults with Mild to Severe Palmoplantar Pustulosis: A 16-Week Treatment Trial

    Recruiting

    2 1
    Investigated Diseases:
    • Palmoplantar pustulosis
    Germany Poland

  • Comparing two forms of mupirocin (gel and ointment) for treating impetigo in children: a study of different dosing schedules

    Recruiting

    3 1 1 1
    Spain
Previous Page
1 … 4 5 6 7 8 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!